Atlas Trials

Renal Effect of Stribild or Other Tenofovir DF-containing Regimens Compared to Ritonavir-boosted Atazanavir Plus Abacavir/Lamivudine in Antiretroviral Treatment-naive HIV-1 Infected Adults

Clinical trial NCT02246998 · COMPLETED

Trial details

NCT number
NCT02246998
Sponsor
Gilead Sciences
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
HIV-1 Infection
Start date
2014-12-15
Primary completion
2016-01-20
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.